Core Laboratories NV Stock Market Outlook
| CLB Stock | USD 13.13 -0.32 -2.38% |
Earnings surprises, macro shifts, and narrative changes can each leave a measurable footprint in the score, which is why sentiment is treated as context rather than proof on its own. About 58% of recent sentiment around Core Laboratories has been mildly defensive over the recent sample. Taken on its own, that leaves the current sentiment reading for Core Laboratories NV close to neutral at this time.
Investor Comfort Level
PanicConfidence
42 · Impartial
Elasticity to Hype and News Sentiment
At 64%, Core Laboratories NV news tone is moderately positive, providing a perception layer that can precede fundamental repricing. Comparing perception data with actual financial results can separate headline-driven pressure from genuine fundamental change.
Over a 90-day investment horizon, with an above-average risk tolerance, the model output for Core Laboratories NV is 'Strong Sell'. The recommendation model incorporates Core Laboratories' available fundamental, technical, and predictive indicators.
Core |
Run Core Laboratories Outlook Model
This Core module delivers a quantitative summary that supplements analyst views on Core Laboratories NV. Macroaxis has no ownership or residual interests in Core Laboratories NV or other analyzed instruments. The Core Laboratories' output adapts to changes in volatility, momentum, and fundamental signals. A balanced approach combines this algorithmic output with broader market research.
How This Model Works
The recommendation output for Core Laboratories is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.
- Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
- Current setup - Three Months with a risk setting described as I am an educated risk taker
- Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates
Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Weak | Details | |
Volatility | Stable | Details | |
Current Valuation | Aligned With Model | Details | |
Odds Of Distress | Minimal | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Core Laboratories' current outlook reflects a cautious setup, where recent market performance has undercut momentum, while contained volatility and intact fundamental quality provide partial offset. The model's 'Strong Sell' signal reflects persistent headwinds that outweigh the offsetting factors in the model. Over the selected time horizon, Core Laboratories shows Mean Deviation of 2.35, Standard Deviation of 3.25, and Variance of 10.54, which weigh on the current risk-reward outlook.The model output for Core Laboratories integrates risk-adjusted performance, valuation signals, and the current analyst and expert consensus into a single quantitative reading. For additional context on this small-cap stock in the Energy sector, examine the full set of Core Laboratories reported fundamentals, including revenue ttm, ebitda ttm, and the relationship between the price to book ttm and cash and equivalents ttm. Core Laboratories has a price to earnings ttm of 101.74 X. Its market performance and bankruptcy risk for the current cycle warrant close attention.
Recent Events and Market Context
The events below reflect recent headlines associated with Core Laboratories. Not all items directly affect the outlook — they are included to show the broader information environment that can shape sentiment and trading behavior.
Returns Distribution Density
This distribution maps every daily return Core Laboratories has posted. Most days cluster near the average return, and the further from the mean, the rarer those moves become. Value At Risk and Upside Potential sit at opposite ends, showing the worst and best likely outcomes. Value At Risk and Upside Potential serve as the key markers for downside and upside.
| Mean Return | -0.55 | Value At Risk | -4.69 | Potential Upside | 3.60 | Standard Deviation | 3.25 |
Return Density |
| Distribution |
Understanding Core Laboratories's risk starts with seeing how often large price swings happen. The historical return chart puts hard numbers on that question. This enables comparison of risk-return profiles with a clear picture of the downside. The chart frames the trade-offs that matter most in the context of analysis of Core Laboratories exposure.
Top Institutional Investors
Core Laboratories NV's institutional and insider mix shapes how the stock trades around earnings. Annual revenue is about 526.52 million. The business currently sits in the Energy sector and the Oil & Gas Equipment & Services industry. Watching turnover and volume trends alongside ownership data adds depth to the picture.
| Shares | Charles Schwab Investment Management Inc | 2025-12-31 | 737.5 K | Fisher Asset Management, Llc | 2026-03-31 | 736.7 K | Gendell Jeffrey L | 2025-12-31 | 648.5 K | Hotchkis & Wiley Capital Management Llc | 2025-12-31 | 551.1 K | Northern Trust Corp | 2025-12-31 | 543.5 K | Morgan Stanley - Brokerage Accounts | 2025-12-31 | 485 K | Bank Of New York Mellon Corp | 2025-12-31 | 411.6 K | American Century Companies Inc | 2025-12-31 | 367.4 K | Van Eck Associates Corporation | 2025-12-31 | 352 K | Ariel Investments, Llc | 2025-12-31 | 13.7 M | Blackrock Inc | 2025-12-31 | 7.2 M |
Key Drivers of Volatility and Market Exposure
Core Laboratories combines broad market sensitivity with company or sector-specific developments. Diversification may lower asset-specific risk, but systematic volatility remains inherent. Core Laboratories NV's financial profile includes a Mean Deviation of 2.35, an Option Implied Volatility of 1.15, and a Standard Deviation of 3.25.
α | Alpha over Dow Jones | -0.5539 | |
β | Beta against Dow Jones | 0.33 | |
σ | Overall volatility | 3.25 | |
Ir | Information ratio | -0.166 |
Fundamentals Vs Peers
Core Laboratories' valuation multiples, profitability ratios, and leverage metrics are benchmarked below against comparable stocks. When Core Laboratories outperforms peers on profitability or returns while trading at a discount, the gap warrants investigation. Core Laboratories's capital efficiency, margin trajectory, and leverage profile are each compared to the peer median. Core Laboratories' financial profile relative to comparable stocks frames the discussion of whether current pricing is justified.
| Better Than Average | Worse Than Average | Compare Core Laboratories to competition |
Note: Disposition of 8069 shares by Martha Carnes of Core Laboratories subject to Rule 16 b-3 [view details]
Market Momentum
Beta of 0.3309 dampens broad market moves. Market-strength indicators for Core Laboratories NV help investors judge how the stock is reacting to changing momentum conditions. The company operates within the Energy sector and the Oil & Gas Equipment & Services industry. Core Laboratories NV momentum view improves when strength data is validated against the fundamental trend.
Recommendation Framework, Assumptions & Editorial Oversight
The model output for Core Laboratories reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Core Laboratories include P/E of 101.74, ROE of 11.06%. External analyst coverage is currently summarized as Hold across 5 analysts, but it is treated here as a secondary reference input rather than a stand-alone recommendation. Published target-price assumptions may also be reviewed when available, but they can change quickly as analyst models are revised. 
Core Laboratories NV data is compiled from periodic company reporting and market reference feeds and standardized for comparability. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.
Editorial Review & Methodology Oversight
Role: Member of Macroaxis Editorial Board
Finance background: Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.